GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Encision Inc (OTCPK:ECIA) » Definitions » Days Sales Outstanding

Encision (Encision) Days Sales Outstanding : 56.15 (As of Dec. 2023)


View and export this data going back to 1996. Start your Free Trial

What is Encision Days Sales Outstanding?

Encision's average Accounts Receivable for the three months ended in Dec. 2023 was $0.97 Mil. Encision's Revenue for the three months ended in Dec. 2023 was $1.58 Mil. Hence, Encision's Days Sales Outstanding for the three months ended in Dec. 2023 was 56.15.

The historical rank and industry rank for Encision's Days Sales Outstanding or its related term are showing as below:

ECIA' s Days Sales Outstanding Range Over the Past 10 Years
Min: 31.99   Med: 41.35   Max: 49.01
Current: 49.01

During the past 13 years, Encision's highest Days Sales Outstanding was 49.01. The lowest was 31.99. And the median was 41.35.

ECIA's Days Sales Outstanding is ranked better than
71.06% of 812 companies
in the Medical Devices & Instruments industry
Industry Median: 65.015 vs ECIA: 49.01

Encision's Days Sales Outstanding increased from Dec. 2022 (47.25) to Dec. 2023 (56.15).


Encision Days Sales Outstanding Historical Data

The historical data trend for Encision's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Encision Days Sales Outstanding Chart

Encision Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 40.89 44.97 46.12 46.93 46.41

Encision Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 47.25 44.21 50.62 48.40 56.15

Competitive Comparison of Encision's Days Sales Outstanding

For the Medical Instruments & Supplies subindustry, Encision's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Encision's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Encision's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Encision's Days Sales Outstanding falls into.



Encision Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Encision's Days Sales Outstanding for the fiscal year that ended in Mar. 2023 is calculated as

Days Sales Outstanding (A: Mar. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Mar. 2022 ) + Accounts Receivable (A: Mar. 2023 )) / count ) / Revenue (A: Mar. 2023 )*Days in Period
=( (0.948 + 0.921) / 2 ) / 7.349*365
=0.9345 / 7.349*365
=46.41

Encision's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (1.024 + 0.923) / 2 ) / 1.582*365 / 4
=0.9735 / 1.582*365 / 4
=56.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Encision  (OTCPK:ECIA) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Encision Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Encision's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Encision (Encision) Business Description

Traded in Other Exchanges
N/A
Address
6797 Winchester Circle, Boulder, CO, USA, 80301
Encision Inc is a medical device company. The company develops and markets technology that provides unprecedented outcomes and patient safety in minimally-invasive surgery. The company has established and developed AEM (Active Electrode Monitoring) technology and surgical instruments which provides surgeons with the desired tissue effects of cutting and coagulating tissue in laparoscopic procedures while preventing stray electrosurgical energy that can cause complications and even death. The segments of the company are Product and Service. Product designs develops, manufactures and markets patented surgical instruments. Service performs electrical engineering activities for external entities.
Executives
Robert H Fries director 800 FILLMORE ST, DENVER CO 80206
Peter D Geary officer: VP of Operations 6797 WINCHESTER CIRCLE, BOULDER CO 80301
Jason E Johnson officer: VP Sales 17752 WEDGEWOOD LANE, PRIOR LAKE MN 55372
Patrick R Dixon director 6797 WINCHESTER CIRCLE, BOULDER CO 80301
Gregory J. Trudel director, officer: CEO 5241 RIMROCK LANE, FORT COLLINS CO 80526
Brian J Jackman director 6797 WINCHESTER CIRCLE, SUITE 100, BOULDER CO 80301
Von Der Lippe Paul director 6797 WINCHESTER CIRCLE, BOULDER CO 80301
Denise Baker director 6797 WINCHESTER CIRCLE, BOULDER X1 80301
Vern D Kornelsen director, 10 percent owner 4605 S. DENICE DR, ENGLEWOOD CO 80111
Partners Lllp Cmed 10 percent owner
Patrick W Pace director 3701 SOARING EAGLE, AUSTIN TX 78746
Michael Biggs officer: VP Engineering 6797 WINCHESTER CIRCLE, BOULDER CO 80301
Brad Greathouse officer: VP RA/QA 6797 WINCHESTER CIRCLE, BOULDER CO 80301
Valerie Ray officer: VP of Operations 6797 WINCHESTER CIRCLE, BOULDER CO 80301
David W Newton director, officer: VP Technology 8099 NORTH 63RD STREET, LONGMONT CO 80503

Encision (Encision) Headlines

From GuruFocus

Encision Receives PPP Financing

By PRNewswire PRNewswire 02-10-2021

Encision Reports First Quarter Fiscal Year 2020 Results

By PRNewswire PRNewswire 08-12-2019

Encision Signs Supplier Agreement with Human Xtensions

By ACCESSWIRE ACCESSWIRE 02-28-2023

Encision Reports Fourth Quarter Fiscal Year 2021 Results

By PRNewswire PRNewswire 05-19-2021

Encision Reports First Quarter Fiscal Year 2023 Results

By ACCESSWIRE ACCESSWIRE 08-09-2022

Encision Introduces Its AEM® 2X enTouch® Scissors

By PRNewswire PRNewswire 08-05-2020

Encision Reports Second Quarter Fiscal Year 2022 Results

By PRNewswire PRNewswire 11-10-2021

Encision Reports Fourth Quarter Fiscal Year 2018 Results

By PRNewswire PRNewswire 05-07-2018

Encision Reports Third Quarter Fiscal Year 2020 Results

By PRNewswire PRNewswire 02-06-2020

Encision Reports First Quarter Fiscal Year 2019 Results

By PRNewswire PRNewswire 08-02-2018